CapsoVision, Inc. (CV)
NASDAQ: CV · Real-Time Price · USD
5.93
-0.13 (-2.15%)
Aug 28, 2026, 4:00 PM EDT - Market closed
CapsoVision Market Cap
CapsoVision has a market cap or net worth of $296.78 million as of August 28, 2026. Its market cap has increased by 60.23% in one year.
Market Cap
296.78M
Enterprise Value
288.39M
1-Year Change
60.23%
Ranking
Category
Stock Price
$5.93
ChartMarket Cap Chart
Since the IPO on July 2, 2025, CapsoVision's market cap has increased from $7.78M to $296.78M, an increase of 3,716.81%. That is a compound annual growth rate of 2,233.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 296.78M | -40.73% |
| Dec 31, 2025 | 500.75M | 6,340.11% |
| Jul 2, 2025 | 7.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mobia Medical | 377.52M |
| Perspective Therapeutics | 355.01M |
| Viemed Healthcare | 335.94M |
| AVITA Medical | 320.09M |
| Treace Medical Concepts | 302.41M |
| TriSalus Life Sciences | 297.41M |
| RxSight | 293.23M |
| Standard BioTools | 252.00M |